000 01078 a2200277 4500
005 20250517230558.0
264 0 _c20190506
008 201905s 0 0 eng d
022 _a1945-7197
024 7 _a10.1210/jc.2018-01094
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aTurnbull, Clare
245 0 0 _aResponse to Letter to the Editor: "p.Val804Met, the Most Frequent Pathogenic Mutation in RET, Confers a Very Low Lifetime Risk of Medullary Thyroid Cancer".
_h[electronic resource]
260 _bThe Journal of clinical endocrinology and metabolism
_c09 2018
300 _a3518-3519 p.
_bdigital
500 _aPublication Type: Letter; Comment
650 0 4 _aHumans
650 0 4 _aMutation
650 0 4 _aProto-Oncogene Proteins c-ret
_xgenetics
650 0 4 _aThyroid Neoplasms
700 1 _aLoveday, Chey
700 1 _aIzatt, Louise
700 1 _aEllard, Sian
773 0 _tThe Journal of clinical endocrinology and metabolism
_gvol. 103
_gno. 9
_gp. 3518-3519
856 4 0 _uhttps://doi.org/10.1210/jc.2018-01094
_zAvailable from publisher's website
999 _c28655936
_d28655936